Moderate riskFDA DeviceClass II

Arrowhead DE Arrow-LOK toe implants recalled over sterility risk

Arrowhead DE LLC is recalling certain Arrow-LOK implants used to fix bones in the lesser toes after corrective surgery. The implants did not complete a required gamma radiation dose audit, which could reduce their sterility and potentially lead to patient infection. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. If you had lesser toe surgery with an Arrow-LOK implant, contact your surgeon or healthcare provider.
  2. Check the REF and lot numbers on your implant records against the recall list.
  3. Report redness, swelling, drainage, or fever at the surgical site to your provider promptly.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Arrow-LOK Implant, REF: 21-253519, 21-253522, 21-253525, 21-253528, 21-253530, 21-253533, 21-253535, 21-253540, 21-253545, 21-253550, 21-353513, 21-353516, 27-253519, 27-253522, 27-253525, 27-253528, 27-253530, 27-253533, 27-253535. Implant indicated for fixation of osteotomies, arthrodeses and reconstruction in the lesser toes following corrective procedures.
Sold in
Nationwide
Made for
Adults (18 years to 100 years)

Details

Units affected
4,171
Illnesses reported
None reported
Manufactured in
401 Westpark Ct Ste 200, Peachtree City, GA, United States
Classification
Class II
Recall number
Z-2958-2026

In the FDA's words

Description
Arrow-LOK Implant, REF: 21-253519, 21-253522, 21-253525, 21-253528, 21-253530, 21-253533, 21-253535, 21-253540, 21-253545, 21-253550, 21-353513, 21-353516, 27-253519, 27-253522, 27-253525, 27-253528, 27-253530, 27-253533, 27-253535. Implant indicated for fixation of osteotomies, arthrodeses and reconstruction in the lesser toes following corrective procedures. Implant did not undergo required gamma radiation dose audit. A potential reduction in sterility assurance could lead to patient infection. REF/UDI-DI/Lot: 21-253519/00855967006035/24662119, 242162; 21-253522/00855967006042/24662122, 242163, 220702; 21-253525/00855967006059/24662125, 220703, 242164; 21-253528/00855967006066/24662128, 242165, 230704; 21-253530/00855967006073/242166, 230705, 220705; 21-253533/00855967006080/24662133, 242167, 230706; 21-253535/00855967006097/24662135, 242168, 230707; 21-253540/00855967006110/242169; 21-253545/00855967006127/242170; 21-253550/00855967006134/24662150; 21-353513/00855967006004/24662113, 242160; 21-353516/00855967006011/24662116, 230701, 242161; 27-253519/00855967006028/24662719, 242171; 27-253522/00855967006141/242172; 27-253525/00855967006158/242173; 27-253528/00855967006165/242174; 27-253530/00855967006172/242175; 27-253533/00855967006189/24662733, 242176; 27-253535/00855967006196/24662735, 242177 Distribution: US Nationwide distribution in the states of VT, FL, TN, NY, GA, TX, HI. Affected quantity: 4,171
Hazard
Implant did not undergo required gamma radiation dose audit. A potential reduction in sterility assurance could lead to patient infection.

Related topics

SterilityMedical devicesSold nationwideMore from FDA Device